Reviewed,
UniProtKB/Swiss-Prot O95292 (VAPB_HUMAN)
Last modified
March 2, 2010.
Version 96.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Vesicle-associated membrane protein-associated protein B/C Short name=VAMP-associated protein B/C Short name=VAMP-B/VAMP-C Short name=VAP-B/VAP-C | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 243 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May play a role in vesicle trafficking. |
| Subunit structure | Homodimer, and heterodimer with VAPA. Interacts with VAMP1 and VAMP2. Interacts with HCV NS5A and NS5B. Ref.7 |
| Subcellular location | Cell membrane; Single-pass type IV membrane protein By similarity. Endomembrane system; Single-pass type IV membrane protein By similarity. Note: Present in the plasma membrane and in intracellular vesicles By similarity. |
| Tissue specificity | Ubiquitous. Isoform 1 predominates. |
| Involvement in disease | Defects in VAPB are the cause of amyotrophic lateral sclerosis type 8 (ALS8) [MIM:608627]. ALS8 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms. Ref.15 Defects in VAPB are a cause of spinal muscular atrophy autosomal dominant Finkel type (SMAF) [MIM:182980]; also called late-onset spinal muscular atrophy Finkel type or spinal muscular atrophy proximal adult autosomal dominant. Spinal muscular atrophy refers to a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. SMAF is characterized by proximal muscle weakness that begins in the lower limbs and then progresses to upper limbs, onset in late adulthood (after third decade) and a benign course. Most of the patients remain ambulatory 10 to 40 years after clinical onset. |
| Sequence similarities | Contains 1 MSP domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Epha4 | Q03137 | 1 | EBI-1188298,EBI-1539152 | From a different organism. |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O95292-1) Also known as: VAP-B; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O95292-2) Also known as: VAP-C; The sequence of this isoform differs from the canonical sequence as follows: 71-99: VMLQPFDYDPNEKSKHKFMVQSMFAPTDT → GRRWTADEEDSAEQQPHFSISPNWEGRRP 100-243: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.6 | ||||||
| Chain | 2 – 243 | 242 | Vesicle-associated membrane protein-associated protein B/C | PRO_0000213473 | |||||
Regions | |||||||||
| Topological domain | 2 – 222 | 221 | Cytoplasmic Potential | ||||||
| Transmembrane | 223 – 243 | 21 | Anchor for type IV membrane protein Potential | ||||||
| Domain | 7 – 124 | 118 | MSP | ||||||
| Coiled coil | 159 – 196 | 38 | Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.13 | ||||||
| Modified residue | 3 | 1 | N6-acetyllysine Ref.14 | ||||||
| Modified residue | 150 | 1 | Phosphothreonine Ref.10 Ref.11 | ||||||
| Modified residue | 156 | 1 | Phosphoserine Ref.13 Ref.11 | ||||||
| Modified residue | 159 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 160 | 1 | Phosphoserine Ref.13 Ref.10 Ref.11 Ref.8 | ||||||
| Modified residue | 206 | 1 | Phosphoserine Ref.13 Ref.10 Ref.9 | ||||||
Natural variations | |||||||||
| Alternative sequence | 71 – 99 | 29 | VMLQP…APTDT → GRRWTADEEDSAEQQPHFSI SPNWEGRRP in isoform 2. | VSP_003277 | |||||
| Alternative sequence | 100 – 243 | 144 | Missing in isoform 2. | VSP_003278 | |||||
| Natural variant | 56 | 1 | P → S in ALS8 and SMAF. Ref.15 | VAR_026743 | |||||
Experimental info | |||||||||
| Sequence conflict | 60 | 1 | I → V in AAF67013. Ref.2 | ||||||
| Sequence conflict | 67 | 1 | I → L in AAF67013. Ref.2 | ||||||
| Sequence conflict | 97 | 1 | T → P in AAF67013. Ref.2 | ||||||
| Sequence conflict | 103 – 106 | 4 | EAVW → DGTR in AAF67013. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins." Nishimura Y., Hayashi M., Inada H., Tanaka T. Biochem. Biophys. Res. Commun. 254:21-26(1999) [PubMed: 9920726] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). Tissue: Brain and Heart. |
| [2] | "Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning." Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X., Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H., Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M. Chen J.-L.Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000) [PubMed: 10931946] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Adrenal gland. |
| [3] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [4] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lymph. |
| [6] | "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J. Nat. Biotechnol. 21:566-569(2003) [PubMed: 12665801] [Abstract] Cited for: PROTEIN SEQUENCE OF 2-19. Tissue: Platelet. |
| [7] | "Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B." Hamamoto I., Nishimura Y., Okamoto T., Aizaki H., Liu M., Mori Y., Abe T., Suzuki T., Lai M.M., Miyamura T., Moriishi K., Matsuura Y. J. Virol. 79:13473-13482(2005) [PubMed: 16227268] [Abstract] Cited for: INTERACTION WITH HCV NS5A AND NS5B. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-160, MASS SPECTROMETRY. Tissue: Epithelium. |
| [9] | "Phosphoproteome analysis of the human mitotic spindle." Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R. Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, MASS SPECTROMETRY. Tissue: Epithelium. |
| [10] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-150; SER-160 AND SER-206, MASS SPECTROMETRY. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-150; SER-156 AND SER-160, MASS SPECTROMETRY. |
| [12] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [13] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-160 AND SER-206, MASS SPECTROMETRY. |
| [14] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3, MASS SPECTROMETRY. |
| [15] | "A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis." Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., Zatz M. Am. J. Hum. Genet. 75:822-831(2004) [PubMed: 15372378] [Abstract] Cited for: VARIANT ALS8/SMAF SER-56. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF086628 mRNA. Translation: AAD13577.1. AF086629 mRNA. Translation: AAD13578.1. AF160212 mRNA. Translation: AAF67013.1. AY358464 mRNA. Translation: AAQ88829.1. AL035455 Genomic DNA. Translation: CAC15021.1. AL035455 Genomic DNA. Translation: CAM27023.1. BC001712 mRNA. Translation: AAH01712.1. |
| IPI | IPI00006211. IPI00748221. |
| PIR | JG0186. |
| RefSeq | NP_004729.1. |
| UniGene | Hs.182625 |
3D structure databases | |
| SMR | O95292. Positions 1-134. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O95292. 4 interactions. |
| STRING | O95292. |
Protein family/group databases | |
| TCDB | 9.B.17.1.1. VAMP-associated protein (VAP) family. |
PTM databases | |
| PhosphoSite | O95292. |
Proteomic databases | |
| PRIDE | O95292. |
Genome annotation databases | |
| Ensembl | ENST00000475243; ENSP00000417175; ENSG00000124164; Homo sapiens. [Genome view] |
| GeneID | 9217. |
| KEGG | hsa:9217. |
| UCSC | uc002xza.1. human. |
Organism-specific databases | |
| CTD | 9217. |
| GeneCards | GC20P056397. |
| H-InvDB | HIX0015950. |
| HGNC | HGNC:12649. VAPB. |
| HPA | CAB013722. HPA013144. |
| MIM | 182980. phenotype. 605704. gene. 608627. phenotype. |
| Orphanet | 209335. Adult-onset proximal spinal muscular atrophy, autosomal dominant. 803. Amyotrophic lateral sclerosis. |
| PharmGKB | PA37273. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG14301. |
| HOGENOM | HBG446464. |
| HOVERGEN | HBG028551. |
| InParanoid | O95292. |
| OMA | VMSKSIS. |
| OrthoDB | EOG9W1101. |
| PhylomeDB | O95292. |
Enzyme and pathway databases | |
| Reactome | REACT_602. Metabolism of lipids and lipoproteins. |
Gene expression databases | |
| ArrayExpress | O95292. |
| Bgee | O95292. |
| CleanEx | HS_VAPB. |
| Genevestigator | O95292. |
| GermOnline | ENSG00000124164. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000535. Major_sperm. IPR008962. PapD-like. IPR016763. Vesicle-associated_membrane. [Graphical view] |
| Gene3D | G3DSA:2.60.40.360. MSP. 1 hit. |
| Pfam | PF00635. Motile_Sperm. 1 hit. [Graphical view] |
| PIRSF | PIRSF019693. VAMP-associated. 1 hit. |
| SUPFAM | SSF49354. PapD-like. 1 hit. |
| PROSITE | PS50202. MSP. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 34553. |
| SOURCE | Search... |
Entry information
| Entry name | VAPB_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O95292 Secondary accession number(s): A2A2F2, O95293, Q9P0H0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


